“Potential Therapy With the Inhibitor of TGF-β Receptors LY2109761 for Oral Squamous Cell Carcinoma”. Research, Society and Development, vol. 10, no. 9, Aug. 2021, p. e54810918396, https://doi.org/10.33448/rsd-v10i9.18396.